Suppr超能文献

是否到了使用益生菌来预防或治疗肥胖的时候了?

Is It Time to Use Probiotics to Prevent or Treat Obesity?

机构信息

Pediatric Clinic, Department of Surgical and Biomedical Sciences, Università degli Studi di Perugia, 06132 Perugia, Italy.

Pharmacology Section, Department of Experimental Medicine, Università degli Studi di Perugia, 06132 Perugia, Italy.

出版信息

Nutrients. 2018 Nov 1;10(11):1613. doi: 10.3390/nu10111613.

Abstract

In recent years, attention has been given to the role potentially played by gut microbiota in the development of obesity. Several studies have shown that in individuals with obesity, the gut microbiota composition can be significantly different from that of lean individuals, that faecal bacteria can exert a fundamental role in modulating energy metabolism, and that modifications of gut microbiota composition can be associated with increases or reductions of body weight and body mass index. Based on this evidence, manipulation of the gut microbiota with probiotics has been considered a possible method to prevent and treat obesity. However, despite a great amount of data, the use of probiotics to prevent and treat obesity and related problems remains debated. Studies have found that the probiotic effect on body weight and metabolism is strain specific and that only some of the species included in the and genera are effective, whereas the use of other strains can be deleterious. However, the dosage, duration of administration, and long-term effects of probiotics administration to prevent overweight and obesity are not known. Further studies are needed before probiotics can be rationally prescribed for the prevention or treatment of obesity. Control of the diet and environmental and life-style factors that favour obesity development remain the best solution to problems related to weight gain.

摘要

近年来,人们越来越关注肠道微生物群在肥胖发展中可能发挥的作用。多项研究表明,在肥胖个体中,肠道微生物群的组成可能与瘦个体有显著差异,粪便细菌可以在调节能量代谢方面发挥重要作用,并且肠道微生物群组成的改变可能与体重和体重指数的增加或减少有关。基于这一证据,用益生菌来操纵肠道微生物群被认为是预防和治疗肥胖的一种可能方法。然而,尽管有大量的数据,益生菌预防和治疗肥胖和相关问题的使用仍然存在争议。研究发现,益生菌对体重和代谢的影响是菌株特异性的,只有 和 属中包含的一些物种是有效的,而使用其他菌株可能是有害的。然而,预防超重和肥胖的益生菌使用的剂量、持续时间和长期效果尚不清楚。在益生菌可以合理地用于预防或治疗肥胖之前,还需要进一步的研究。控制饮食以及有利于肥胖发展的环境和生活方式因素仍然是解决与体重增加相关问题的最佳方案。

相似文献

1
Is It Time to Use Probiotics to Prevent or Treat Obesity?
Nutrients. 2018 Nov 1;10(11):1613. doi: 10.3390/nu10111613.
4
Influence of the microbiota and probiotics in obesity.
Clin Investig Arterioscler. 2018 Nov-Dec;30(6):271-279. doi: 10.1016/j.arteri.2018.03.004. Epub 2018 May 25.
6
Gut microbiota is associated with adiposity markers and probiotics may impact specific genera.
Eur J Nutr. 2020 Jun;59(4):1751-1762. doi: 10.1007/s00394-019-02034-0. Epub 2019 Jun 27.
8
Gut enterotypes are stable during Bifidobacterium and Lactobacillus probiotic supplementation.
J Food Sci. 2020 May;85(5):1596-1604. doi: 10.1111/1750-3841.15127. Epub 2020 Apr 8.
9
Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of Probiotics.
PLoS One. 2015 Sep 17;10(9):e0137681. doi: 10.1371/journal.pone.0137681. eCollection 2015.
10
The Role of Probiotics on the Microbiota: Effect on Obesity.
Nutr Clin Pract. 2016 Jun;31(3):387-400. doi: 10.1177/0884533615620350. Epub 2016 Feb 11.

引用本文的文献

3
Fecal Microbiota Characteristics in Constipation-Predominant and Mixed-Type Irritable Bowel Syndrome.
Microorganisms. 2024 Jul 12;12(7):1414. doi: 10.3390/microorganisms12071414.
5
Gut microbiota: a potential new regulator of hypertension.
Front Cardiovasc Med. 2024 Jun 27;11:1333005. doi: 10.3389/fcvm.2024.1333005. eCollection 2024.
10
Current understanding of antibiotic-associated dysbiosis and approaches for its management.
Ther Adv Infect Dis. 2023 Feb 24;10:20499361231154443. doi: 10.1177/20499361231154443. eCollection 2023 Jan-Dec.

本文引用的文献

1
Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?
Curr Diab Rep. 2018 Sep 13;18(10):98. doi: 10.1007/s11892-018-1057-6.
2
The impact of the intestinal microbiome on bone health.
Intractable Rare Dis Res. 2018 Aug;7(3):148-155. doi: 10.5582/irdr.2018.01055.
3
A next-generation beneficial microbe: .
J Clin Biochem Nutr. 2018 Jul;63(1):33-35. doi: 10.3164/jcbn.18-57. Epub 2018 Jun 20.
4
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer.
Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):671-682. doi: 10.1038/s41575-018-0025-6.
5
An update on physical health and economic consequences of overweight and obesity.
Diabetes Metab Syndr. 2018 Nov;12(6):1095-1100. doi: 10.1016/j.dsx.2018.05.004. Epub 2018 May 5.
9
Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics.
J Infect. 2018 Feb;76(2):111-120. doi: 10.1016/j.jinf.2017.12.013. Epub 2017 Dec 29.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验